LINC00342 and nonpapillary renal cell carcinoma: Silencing LINC00342 by siRNA inhibited the glycolytic level and migration abilities of 786-O cells, these results indicated the crucial role of LINC00342 in ccRCC glucose metabolic reprogramming and metastasis.